Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18-70 years~* Nondiabetic patients~* Patients with primary glomerulonephritis~* Clinical diagnosis of membranous nephropathy, IgA nephropathy or focal segmental glomerulosclerosis confirmed by biopsy~* Glomerular filtration rate \> 30 mL/min~* Patients who did not receive Helicobacter pylori eradication therapy within the last three months before enrollment in study~Exclusion Criteria:~* Patients with secondary glomerulonephritis~* Glomerular filtration rate \< 30 mL/min~* Patients who received Helicobacter pylori eradication therapy within the last three months before enrollment in study~* Patients with a history of gastric surgery~* Patients without an informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Membranous nephropathy (Type: ACTIVE_COMPARATOR): Patients with primary membranous nephropathy diagnosed by biopsy
- IgA nephropathy (Type: ACTIVE_COMPARATOR): Patients with IgA nephropathy diagnosed by biopsy
- Focal segmental glomerulosclerosis (Type: ACTIVE_COMPARATOR): Patients with primary focal segmental glomerulosclerosis diagnosed by biopsy

Based on this trial design, predict the completion outcome and termination type (if applicable).